Loading organizations...
Mamedica operates as a UK-based medical cannabis clinic, providing online consultations with specialist doctors for prescription medicines. It integrates clinic services with a distanced selling pharmacy, offering a streamlined digital platform. This model delivers accessible, regulated care for individuals with chronic and neurological conditions seeking alternative treatments.
Founded by Jon Robson in 2021, with operations starting in 2022, Mamedica aimed to fulfill a need for superior patient care in the UK medical cannabis sector. Robson recognized gaps in quality and accessibility for patients unresponsive to conventional treatments, prompting him to establish a company focused on elevating service standards.
Mamedica serves UK patients suffering from chronic and neurological conditions eligible for medical cannabis. It expands access through initiatives like its Access Scheme, benefiting veterans and benefit recipients. Mamedica's vision is to improve lives by pioneering UK medical cannabis, promoting education, and ensuring widely available, high-quality, regulated care.
Mamedica has raised $6.0M across 1 funding round.
Mamedica has raised $6.0M in total across 1 funding round.
Mamedica is a London-based medical cannabis clinic that provides virtual consultations and prescribes cannabis-based prescription medicines (CBPMs) for conditions including chronic pain, mental health disorders (anxiety, depression, insomnia, PTSD), and neurological conditions; it was founded in 2021 and launched services in 2022 under founder and CEO Jon Robson[2][3].
High-Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech/Health Landscape
Quick Take & Future Outlook
Quick reminder: statements above are drawn from Mamedica’s site, company press coverage and public profiles summarising the clinic’s history, services and partnerships[3][2][1][5]. If you’d like, I can prepare a one-page investor-style memo with patient-growth metrics, supplier/partnership timeline, regulatory risks and competitive landscape.
Mamedica has raised $6.0M in total across 1 funding round.
Mamedica's investors include Alt Capital, Better Tomorrow Ventures, Casa Verde Capital, Fuel Capital, Insight Partners, Rackhouse Venture Capital, Sequoia Capital, Leah Busque, Sam Altman.
Mamedica has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Seed in September 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2025 | $6M Seed | — | ALT Capital, Better Tomorrow Ventures, Casa Verde Capital, Fuel Capital, Insight Partners, Rackhouse Venture Capital, Sequoia Capital, Leah Busque, SAM Altman | Announced |